Latest News about BMY
Recent news which mentions BMY
7 Stocks Primed for a Spectacular Comeback in 2024
January 03, 2024
From InvestorPlace
This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns
January 03, 2024
From Benzinga
3 Strong Dividend Stocks to Buy Early On in 2024
January 03, 2024
From Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
December 29, 2023
From Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
From Benzinga
Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch
December 28, 2023
From Benzinga
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
From Benzinga
Why Is Blood Purification Focused CytoSorbents Trading Lower Today?
December 28, 2023
From Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
December 27, 2023
From InvestorPlace
Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned
December 27, 2023
From Benzinga
Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday
December 27, 2023
From Benzinga
Bristol-Myers' Acquisition Of Karuna Therapeutics Paves Way For Aggressive Global Marketing Of KarXT: Analyst
December 26, 2023
From Benzinga
Why Is RayzeBio (RYZB) Stock Up 100% Today?
December 26, 2023
From InvestorPlace
Health Care Company Bristol-Myers Squibb Announces Merger With RayzeBio
December 26, 2023
From Benzinga
Bristol Myers Squibb Takes On Novartis, Eli Lilly With RayzeBio $4B Deal In Radiopharmaceuticals
December 26, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 25, 2023
From Benzinga
From Motley Fool
Dow Edges Lower; Nike Sales Miss Estimates
December 22, 2023
From Benzinga
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
From Benzinga
HBM Gets Health Boost From Drug Licensing Deals
December 22, 2023
From Benzinga
S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?
December 22, 2023
From Benzinga
Gold Moves Higher; US Consumer Sentiment Improves In December
December 22, 2023
From Benzinga
With Karuna Therapeutics $14B Deal, Bristol Myers Is Serious For Re-Establishing Its Neurology Portfolio: Analyst
December 22, 2023
From Benzinga
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
December 22, 2023
From Benzinga
Health Care Company Bristol-Myers Squibb Announces Merger With Karuna Therapeutics
December 22, 2023
From Benzinga
Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In November
December 22, 2023
From Benzinga
Bristol Myers Squibb Scoops Up Schizophrenia Player Karuna Therapeutics In Massive $14B Deal
December 22, 2023
From Benzinga
3 Potential Turnaround Stocks to Buy for Big Rewards in 2024
December 20, 2023
From InvestorPlace
Better Dividend Stock: Bristol Myers Squibb or Merck?
December 19, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.